Research programme: huntingtin decoy peptides - Massachusetts Institute of Technology
Alternative Names: Huntingtin decoy peptides research programme - Massachusetts Institute of TechnologyLatest Information Update: 22 Jan 2003
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Huntington's disease
Most Recent Events
- 01 May 2001 Preclinical development for Huntington's disease in USA (Unknown route)